CPHD -19% AH# Stock
T*C
1 楼
7:26 PM Cepheid (CPHD) has resumed trading, currently changing hands at $35
, -19% in the post-session.
Comment!
[On the Move, Healthcare]
4:52 PM More on Cepheid (CPHD): Q2 comes in-line on a per share basis but
comes up shy on revenue despite a 20% Y/Y jump in total sales. Looking
forward into the second half however, the company says it's taking a more
cautious view. For FY 2012, the company expects revenue in the range of $
333M to $347M and an EPS of $0.38 to $0.42 per share. The Street is at $342M
in revenue on earnings of $0.49 per share. Shares remain halted AH.
Comment!
[Healthcare, Earnings]
4:25 PM Cepheid (CPHD): Q2 EPS of $0.11 in-line. Revenue of $81M (+20.8% Y/Y
) misses by $1.7M. (PR)
Comment!
[Earnings, Tech]
, -19% in the post-session.
Comment!
[On the Move, Healthcare]
4:52 PM More on Cepheid (CPHD): Q2 comes in-line on a per share basis but
comes up shy on revenue despite a 20% Y/Y jump in total sales. Looking
forward into the second half however, the company says it's taking a more
cautious view. For FY 2012, the company expects revenue in the range of $
333M to $347M and an EPS of $0.38 to $0.42 per share. The Street is at $342M
in revenue on earnings of $0.49 per share. Shares remain halted AH.
Comment!
[Healthcare, Earnings]
4:25 PM Cepheid (CPHD): Q2 EPS of $0.11 in-line. Revenue of $81M (+20.8% Y/Y
) misses by $1.7M. (PR)
Comment!
[Earnings, Tech]